JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Harwood, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Harwood, D. L.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 314-325, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia

LA Robinson and DL Harwood
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-2315.

The concentration of calcium (1.2 mmol/L) in clinical St. Thomas' Hospital cardioplegic solution was chosen several years ago after dose- response studies in the normothermic isolated heart. However, recent studies with creatine phosphate in St. Thomas' Hospital solution demonstrated that additional myocardial protection during hypothermia resulted principally from its calcium-lowering effect in the solution. The isolated working rat heart model was therefore used to establish the optimal calcium concentration in St. Thomas' Hospital solution during lengthy hypothermic ischemia (20 degrees C, 300 minutes). The calcium content of standard St. Thomas' Hospital solution was varied from 0.0 to 1.5 mmol/L in eight treatment groups (n = 6 for each group). During ischemia, hearts were exposed to multidose cardioplegia (3 minutes every 30 minutes). Postischemic recovery of function was expressed as a percentage of preischemic control values. Release of creatine kinase and the time to return of sinus rhythm during the reperfusion period were also measured. These dose-response studies during hypothermic ischemia revealed a broad range of acceptable calcium concentrations (0.3 to 0.9 mmol/L), which appear optimal in St. Thomas' Hospital solution at 0.6 mmol/L. This concentration improved the postischemic recovery of aortic flow from 22.0% +/- 5.9% with control St. Thomas' Hospital solution (calcium concentration 1.2 mmol/L) to 86.0% +/- 4.0% (p less than 0.001). Other indices of functional recovery showed similar dramatic results. Creatine kinase release was reduced 84% (p less than 0.01) in the optimal calcium group. Postischemic reperfusion arrhythmias were diminished with the loser calcium concentration, with a significant decrease in the time between initial reperfusion until the return of sinus rhythm. In contrast, acalcemic St. Thomas' Hospital solution precipitated the calcium paradox with massive enzyme release and no functional recovery. Unlike prior published calcium dose-response studies at normothermia, these results demonstrate that the optimal calcium concentration during clinically relevant hypothermic ischemia is considerably lower than that of normal serum ionized calcium (1.2 mmol/L) and appears ideal at 0.6 mmol/L to realize even greater cardioprotective and antiarrhythmic effects with St. Thomas' Hospital solution.


This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
J. An, A. K. S. Camara, Q. Chen, and D. F. Stowe
Effect of low [CaCl2] and high [MgCl2] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts
Eur J Cardiothorac Surg, December 1, 2003; 24(6): 974 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Warnecke, B. Schulze, C. Hagl, A. Haverich, and U. Klima
Improved right heart function after myocardial preservation with 2,3-butanedione 2-monoxime in a porcine model of allogenic heart transplantation
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. H. Chen
The Scientific Basis for Hypocalcemic Cardioplegia and Reperfusion in Cardiac Surgery
Ann. Thorac. Surg., September 1, 1996; 62(3): 910 - 914.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
F. L. Rosenfeldt, R. A. J. Conyers, P. Jablonski, L. Langley, S. M. Richards, G. Self, and V. Marshall
Comparison of UW Solution and St. Thomas' Solution in the Rat: Importance of Potassium Concentration
Ann. Thorac. Surg., February 1, 1996; 61(2): 576 - 584.
[Abstract] [Full Text]


Home page
CirculationHome page
M. J. Taylor, J. E. Bailes, A. M. Elrifai, S.-R. Shih, E. Teeple, M. L. Leavitt, J. G. Baust, and J. C. Maroon
A New Solution for Life Without Blood : Asanguineous Low-Flow Perfusion of a Whole-Body Perfusate During 3 Hours of Cardiac Arrest and Profound Hypothermia
Circulation, January 15, 1995; 91(2): 431 - 444.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. J. Baker and J. E. Baker
Calcium and cardioplegic protection of the ischemic immature heart: Impact of hypoxemia from birth
Ann. Thorac. Surg., October 1, 1994; 58(4): 1123 - 1130.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. C. Stringham, K. L. Paulsen, J. H. Southard, R. M. Mentzer Jr., and F. O. Belzer
Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium
J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 764 - 775.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Aoki, F. Nomura, and J. E. Mayer Jr.
Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart
J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 822 - 828.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
N. Takemoto, H. Kuroda, T. Hamasaki, Y. Hara, S. Ishiguro, and T. Mori
Effect of magnesium and calcium on myocafdial protection by cardioplegic solutions
Ann. Thorac. Surg., January 1, 1994; 57(1): 177 - 182.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. E. Baker, L. E. Boerboom, and G. N. Olinger
Age and protection of the ischemic myocardium: Is alkaline cardioplegia appropriate?
Ann. Thorac. Surg., March 1, 1993; 55(3): 747 - 755.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. L. Bove and K. P. Gallagher
Reply
Ann. Thorac. Surg., June 1, 1991; 51(6): 1044 - 1044.
[PDF]


Home page
Ann. Thorac. Surg.Home page
L. A. Robinson
Calcium in neonatal cardioplegia
Ann. Thorac. Surg., June 1, 1991; 51(6): 1043 - 1044.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The American Association for Thoracic Surgery.